Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells.

Achia Urbach,1,2,4 Ori Bar-Nur,3,4 George Q. Daley,1,2,* and Nissim Benvenisty3,* 1Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Children’s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham and Women’s Hospital, Boston, MA 02115, USA 2Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; Harvard Stem Cell Institute, Boston, MA 02115, USA 3Stem Cell Unit, Department of Genetics, Institute of Life Sciences, The Hebrew University, Jerusalem 91904, Israel 4These authors contributed equally to this work *Correspondence: [email protected] (G.Q.D.), [email protected] (N.B.) DOI 10.1016/j.stem.2010.04.005